- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Spinocerebellar Ataxia Type 2 in New Zealand
Total 1217 results
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; Pharmacyclics LLC.TerminatedFollicular Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade IIIaUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, South Africa, Hong Kong, Taiwan, Philippines
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Meningiomas | Vestibular SchwannomasUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Mexico, Spain, Estonia, Pakistan, Philippines
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Italy, United Kingdom, France, Serbia, Germany, South Africa, Canada, Ukraine, United Arab Emirates
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Brazil
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
TakedaTerminatedDiabetes Mellitus, Type 2United States, Poland, Bulgaria, Romania, Canada, Hungary, Slovakia
-
NYU Langone HealthCompletedNeurofibromatosis Type 2 | Vestibular SchwannomasUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States, Mexico, Canada, United Kingdom, India, Belgium, Taiwan
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Czech Republic, Russian Federation, Ukraine
-
NYU Langone HealthGlaxoSmithKlineCompletedNeurofibromatosis 2 | Vestibular SchwannomaUnited States
-
Novo Nordisk A/SCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Romania, Ukraine, Germany, Italy, Estonia, Malaysia, Philippines, Mexico, Lithuania, Colombia, Slovakia, Chile
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Malaysia, South Africa, Philippines, Australia, India, Saudi Arabia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Hungary, France, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Germany, Lithuania
-
SanofiCompletedDiabetes Mellitus, Type 2United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, United Kingdom, Belgium, Spain, Israel, Mexico, Australia, Russian Federation, Hungary, France, Guatemala, Puerto Rico
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Hungary, Poland, Germany, France
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Italy, Mexico, Poland, Russian Federation, Slovakia, United Kingdom, Argentina, Norway, Turkey, Israel, Czechia, South Africa, Hungary, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1India
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Yale UniversityTerminatedObesity | Diabetes Mellitus, Type 2 | SchizophreniaUnited States
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SWithdrawnDiabetes Mellitus, Type 2United States, Sweden, Austria, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Finland, Taiwan, United States, Korea, Republic of, China, Australia, Portugal, Japan, India, Russian Federation, Norway, Italy, Mexico, Turkey, Poland, Belgium, Bulgaria, Croatia, Puerto Rico, Romania, Serbia, South Africa
-
Montefiore Medical CenterAlbert Einstein College of Medicine; Deciphera Pharmaceuticals LLCTerminatedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast AdenocarcinomaUnited States
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Belgium, Spain, Taiwan, Korea, Republic of, Japan, Italy, Denmark, Israel, Canada, France, India, Netherlands, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Italy, Mexico, Russian Federation, United Kingdom, Spain, Malaysia, Croatia, Greece, Korea, Republic of, Japan, South Africa, Algeria, Thailand, Argentina, Brazil, Canada, Romania
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Taiwan, Argentina, Canada, Philippines, Korea, Republic of, Mexico, Brazil, Pakistan
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Turkey, Canada, Finland, France, Hungary, Korea, Republic of
-
SanofiTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Czechia, Hungary, Poland, Serbia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, India, Malaysia, Turkey, Argentina, Greece, Australia, Portugal, Thailand, Brazil
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States
-
Bristol-Myers SquibbCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, India, China, Brazil, Greece, Malaysia, Mexico, Philippines, Poland, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Australia, Philippines, Mexico, Puerto Rico